Lanatozid C
Sodium chloride
Trade Name:
Product Code:
Active Substance:
Dosage/Volume:
Pharmaceutical Form:
Package:
ATC Classification System:
OTC:
RX:
Product Registration:
Lanatozid C – 0.4 mg / 2 ml Solution for injection
Lanatozid C is a cardiac glycoside with positive inotropic effect. Its effects are similar with digoxin. It increases the myocardial contraction strength and decreases myocardial conductivity, especially the conductivity through the AV node.
Lanatozid C exerts positive inotropic effect and negative chronotropic effect.
Approximately 20% of the used dose is inactivated within 24 hours. Its effects disappear after 3 – 6 days. Digoxin is the metabolite of lanatoside C and it is eliminated through urine.
Lanatozid C is indicated in:
• the treatment of mild to moderately severe heart failure
• the treatment of paroxysmal supraventricular tachycardia.
ATC CODE:
C01AA06
Shelf life:
36 months
